
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aram... Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.09 | 5.55555555556 | 1.62 | 1.79 | 1.53 | 354285 | 1.67280275 | CS |
4 | 0.45 | 35.7142857143 | 1.26 | 1.79 | 1.25 | 281890 | 1.52637632 | CS |
12 | -0.25 | -12.7551020408 | 1.96 | 2.68 | 1.15 | 1725186 | 1.57383821 | CS |
26 | -1.58 | -48.0243161094 | 3.29 | 3.61 | 1.15 | 1261837 | 1.88771707 | CS |
52 | -2.286 | -57.2072072072 | 3.996 | 23.8 | 1.15 | 1389680 | 7.02411753 | CS |
156 | -81.09 | -97.9347826087 | 82.8 | 170.1 | 1.15 | 568398 | 13.19717406 | CS |
260 | -901.89 | -99.8107569721 | 903.6 | 1126.782 | 1.15 | 413863 | 115.80475027 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.